Abridge

Builds ambient AI that turns clinician-patient conversations into structured clinical notes for health systems.

View on the globe

$550MEquity raised in 2025–20262025 $550M · 2026 — · 2 equity rounds
$550MEquity raised, all time2 equity rounds sourced so far
$5.3BLatest valuationpost-money, as reported

Rounds over time log-scaled amounts

Funding history: 2 rounds from 17 Feb 2025 to 24 Jun 2025, $550M equity disclosed, latest valuation $5.3B. Earlier rounds exist but are not sourced.17 Feb 2025: Series D, $250M, valued at $2.8B; 24 Jun 2025: Series E, $300M, valued at $5.3B$100M$300M$1B$3B$10BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2018Q42025Q2Q3Q42026Equity roundPost-money valuation17 Feb 2025 · Series D · valued at $2.8B24 Jun 2025 · Series E · valued at $5.3B24 Jun 2025 · Series E · $300M at $5.3B · led by Andreessen Horowitz17 Feb 2025 · Series D · $250M at $2.8B · led by Elad Gil, IVP$5.3BSeries E · $300MSeries D · $250M
Funding history: 2 rounds from 17 Feb 2025 to 24 Jun 2025, $550M equity disclosed, latest valuation $5.3B. Earlier rounds exist but are not sourced.17 Feb 2025: Series D, $250M, valued at $2.8B; 24 Jun 2025: Series E, $300M, valued at $5.3B$100M$300M$1B$3B$10BEarlier rounds exist but are not sourced yetearlier rounds not sourced’18Q42025Q2Q3Q42026Equity roundValuation17 Feb 2025 · Series D · valued at $2.8B24 Jun 2025 · Series E · valued at $5.3B24 Jun 2025 · Series E · $300M at $5.3B · led by Andreessen Horowitz17 Feb 2025 · Series D · $250M at $2.8B · led by Elad Gil, IVP$5.3B$300M$250M

Funding history 2 rounds · 4 sources · newest first

Earlier rounds not yet sourced. Abridge was founded in 2018 and raised before 17 Feb 2025; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series E
    Amount$300M
    Post-money$5.3B
    ✓ Confirmed
    Lead
    Andreessen Horowitz
    Also
    Khosla Ventures
    Note
    Both articles cite the Wall Street Journal for the figures.
    Sources
  2. Series D
    Amount$250M
    Post-money$2.8B
    ✓ Confirmed
    Lead
    Elad Gil, IVP
    Note
    Valuation as reported by Fortune (about $2.75B post-money); not stated by the company. Earlier rounds are not sourced here.
    Sources
  3. Earlier rounds not yet sourced

Investors 4

  • Andreessen Horowitz1
  • Elad Gil1
  • IVP1
  • Khosla Ventures

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Pittsburgh hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Abridge and its logo are trademarks of their owners, used here for identification only.